Literature DB >> 10651201

Plasma and urinary levels of heart fatty acid-binding protein in patients undergoing cardiac surgery.

N Hayashida1, S Chihara, K Akasu, T Oda, E Tayama, E Kai, T Kawara, S Aoyagi.   

Abstract

To evaluate the clinical significance of the plasma and urinary levels of heart fatty acid-binding protein (H-FABP) in patients undergoing cardiac surgery, a prospective study was conducted. Ten patients undergoing coronary artery bypass grafting were enrolled. Blood samples for determination of plasma H-FABP (pH-FABP), the MB isoenzyme of creatine kinase (CK-MB) and troponin-T (TnT), and urine samples for determination of urinary H-FABP (uH-FABP) were collected serially. None of the patients had perioperative myocardial infarction. The time to reach the peak level after aortic declamping was significantly (p<0.05) shorter for pH-FABP (1.4+/-0.5 h) than for CK-MB (2.5+/-0.5 h), TnT (6.6+/-1.3 h) or uH-FABP (3.0+/-0.6 h). Peak levels of pH-FABP correlated with those of CK-MB (r = 0.51, p = 0.04), TnT (r = 0.60, p = 0.03) and uH-FABP (r = 0.61, p = 0.03), and peak levels of uH-FABP correlated with CK-MB (r = 0.57, p = 0.04). Postoperative uH-FABP levels correlated inversely with the left ventricular stroke work index (r = -0.63, p = 0.04). This study demonstrated that H-FABP appears rapidly in plasma after reperfusion and reaches its peak earlier than other available biochemical markers; it appears also in urine and the levels correlated with cardiac function. Plasma and urinary H-FABP may be an early and sensitive biochemical marker for the diagnosis of myocardial injury in patients undergoing cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10651201     DOI: 10.1253/jcj.64.18

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  6 in total

1.  Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery.

Authors:  Jochen D Muehlschlegel; Tjörvi E Perry; Kuang-Yu Liu; Amanda A Fox; Charles D Collard; Stanton K Shernan; Simon C Body
Journal:  Anesth Analg       Date:  2010-05-10       Impact factor: 5.108

2.  Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease.

Authors:  Ben Li; Abdelrahman Zamzam; Muzammil H Syed; Niousha Jahanpour; Shubha Jain; Rawand Abdin; Mohammad Qadura
Journal:  Front Cardiovasc Med       Date:  2022-06-20

3.  Heart-type fatty acid-binding protein: an overlooked cardiac biomarker.

Authors:  Harsh Goel; Joshua Melot; Matthew D Krinock; Ashish Kumar; Sunil K Nadar; Gregory Y H Lip
Journal:  Ann Med       Date:  2020-08-04       Impact factor: 4.709

Review 4.  Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis.

Authors:  Xiao-Dong Ye; Yi He; Sheng Wang; Gordon T Wong; Michael G Irwin; Zhengyuan Xia
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

5.  Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease.

Authors:  Abdelrahman Zamzam; Muzammil H Syed; John Harlock; John Eikelboom; Krishna K Singh; Rawand Abdin; Mohammad Qadura
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

6.  Preoperative serum h-FABP concentration is associated with postoperative incidence of acute kidney injury in patients undergoing cardiac surgery.

Authors:  Mehmet Oezkur; Armin Gorski; Jennifer Peltz; Martin Wagner; Maria Lazariotou; Christoph Schimmer; Peter U Heuschmann; Rainer G Leyh
Journal:  BMC Cardiovasc Disord       Date:  2014-09-12       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.